← Back to generic index

Levocetirizine Dihydrochloride — brands & medicines in Pakistan

Pakistan mein Levocetirizine Dihydrochloride ke 1 brands available hain. Drug class: Antihistamine. Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.

Quick Answer

Levocetirizine Dihydrochloride is a antihistamine used in Pakistan for Seasonal allergic rhinitis (seasonal allergy), Perennial allergic rhinitis (year-round allergy), Chronic idiopathic urticaria (chronic hives). Available as 1 brand. Available without a prescription in Pakistan. Always confirm dose with a doctor or pharmacist.

What is Levocetirizine Dihydrochloride?

Levocetirizine Dihydrochloride is a antihistamine used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Levocetirizine Dihydrochloride under multiple brand names — currently 1 listed on PakVita (1 tablet). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.

Common indications

  • Seasonal allergic rhinitis (seasonal allergy)
  • Perennial allergic rhinitis (year-round allergy)
  • Chronic idiopathic urticaria (chronic hives)
  • Sneezing and a runny nose (sneeze aur runny nose)
  • Itchy, watery, and red eyes (itchy, watery eyes)
  • Itchy nose and throat (itchy nose aur throat)
  • Skin itching and allergic rashes (skin allergy rash)

Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.

Typical dosage

As prescribed

This is a general adult guidance pattern based on the manufacturer's label for one of the Levocetirizine Dihydrochloride brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.

Side effects

Common (usually mild)

  • Drowsiness/somnolence
  • Dry mouth
  • Fatigue

Serious — stop and see a doctor

  • Severe headache
  • Persistent dizziness
  • Nasopharyngitis (sore throat)

Important warnings

  • Don't use Neo Sedil Tablet if you are allergic to Levocetirizine or Cetirizine
  • Patients with end-stage renal disease should not take this medicine

Levocetirizine Dihydrochloride brands in Pakistan (1)

Click any brand to see full uses, dosage, side effects, prices, and warnings.

Frequently asked questions

What is Levocetirizine Dihydrochloride used for in Pakistan?

Levocetirizine Dihydrochloride is commonly used for Seasonal allergic rhinitis (seasonal allergy), Perennial allergic rhinitis (year-round allergy), Chronic idiopathic urticaria (chronic hives), Sneezing and a runny nose (sneeze aur runny nose), and other indications. It belongs to the antihistamine drug class.

What is the typical dosage of Levocetirizine Dihydrochloride?

Typical adult dosing is described by manufacturers as: "As prescribed". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.

What are the common side effects of Levocetirizine Dihydrochloride?

Common side effects include Drowsiness/somnolence, Dry mouth, Fatigue. Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).

When should I stop Levocetirizine Dihydrochloride and see a doctor?

Stop Levocetirizine Dihydrochloride and seek urgent medical care if you experience: Severe headache; Persistent dizziness; Nasopharyngitis (sore throat). These are serious signs that need immediate attention.

Is Levocetirizine Dihydrochloride available without a prescription in Pakistan?

Available without a prescription in Pakistan.

What brands of Levocetirizine Dihydrochloride are available in Pakistan?

1 brand of Levocetirizine Dihydrochloride is listed on PakVita: 1 tablet. Browse the brand list below and click any name for prices, dosage, and full information.

Sources

  1. DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
  2. British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
  3. WHO Model List of Essential Medicines, 23rd ed. — World Health Organization